XiaoMi-AI文件搜索系统
World File Search SystemDaclatasvir
D-SNP（HMO）提供者和护理培训模型
5。是否要求使用含有或不含NS5A抑制剂的Sofosbuvir治疗的丙型肝炎病毒（HCV）撤退（例如，Daclatasvir，Elbasvir，Elbasvir，Ledipasasvir，ledipasvir，pibrentasvir，pibrentasvir，pibrentasvir，pibrentasvir，pibrentasvir，pibibrentasvir，pibibrentasvir，pibrentasvir，or velpatasvir）？
此信息旨在由卫生专业人员使用
amiodarone，Canagliflozin，Daclatasvir，Flibanserin，Flecainide，prazosin，prapafenone，propafenone，Quinidine，螺丝酮，大花生酸酯，大花环抗生素，例如。erythromycin and clarythromycin, tetracycline (and possibly other antibiotics), gentamicin, isavuconazole, itraconazole, ivacaftor, quinine, trimethoprim, alprazolam, indomethacin, propantheline, mirabegron, nefazodone, atorvastatin, ciclosporine, epoprostenol (transient), vasopressin receptor antagonists (tolvaptan and conivaptan), carvedilol, ritonavir/ritonavir containing regimens, taleprevir, dronedarone, ranolazine, simeprevir, telmisartan, lapatinib, ticagrelor, vandetanib, velpatasvir, venetoclax and vemurafenib。。血清高辛浓度应受到监测并用于滴定地高辛。